Method for detecting fusion gene based on DNA-based sequencing data
By combining multiple detection and filtering models of software such as Genefuse, Factera and Arriba, the false positive and false negative problems of DNA-based sequencing data detection of fusion genes in the prior art are solved, and the detection accuracy and detection rate are improved. More reliable clinical diagnostic support.
Patent Information
- Application Number
- CN202411217530.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-02
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2044-09-02
AI Technical Summary
The existing software for detecting fusion genes based on DNA-based sequencing data has false positive or false negative problems, and the lack of effective multi-software fusion detection methods, resulting in inaccurate detection results.
The multi-software fusion detection method was adopted to filter and verify DNA sequencing data multiple times through software such as Genefuse, Factera and Arriba, and build a fusion gene filtering model, combining parameter settings and comparison results of different software to improve the accuracy of the detection.
It effectively reduces false positives and false negatives, improves the accuracy and detection rate of fusion gene detection, enhances the detection ability of different types of fusion genes, and provides more reliable clinical diagnostic data support.
Smart Images

Figure CN119091965A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of gene detection, and in particular to a method for detecting fusion genes based on DNA-based sequencing data. Background Art
[0002] Fusion genes refer to a new gene formed by the fusion of all or part of the coding or non-coding regions of two or more different genes due to a certain mechanism (such as genomic variation). It is caused by chromosome structural rearrangement. Fusion genes are closely related to the occurrence and development of tumors. By identifying related fusion genes, biomarkers can be diagnosed, new therapeutic targets can be discovered, and the molecular basis of tumor occurrence can be understood.
[0003] At present, the commonly used clinical detection methods for fusion genes include immunohistochemistry, FISH, PCR and second-generation sequencing. The second-generation sequencing technology has a wide detection range and fast detection speed. It can simultaneously verify whether the gene is fused at the gene level and the transcriptome level and accurately detect the breakpoints of the fusion gene, making up for the problems of missed detection and inability to identify the fusion partner gene in conventional detection methods. Among them, the methods of using second-generation sequencing to detect fusion genes include DNA-based second-generation sequencing methods and RNA-based second-generation sequencing methods.
[0004] The DNA-based detection method for detecting fusion genes mainly compares the double-end sequencing sequence with the genome, evaluates whether the distance and direction of the double-end sequencing sequence are consistent with the library construction information, and then determines whether it is a fusion gene. Commonly used software includes Genefuse and Factera. The RNA-based detection method for fusion genes includes sequence alignment-based methods and splicing alignment-based methods. The former identifies fusion events by finding inconsistent sequences and sequences covering breakpoints, and the latter assembles transcripts and then aligns them to the reference genome to identify fusion transcripts consistent with chromosome rearrangement. Commonly used software includes Arriba.
[0005] Among them, Genefuse is a DNA-based sequencing tool that can detect fusion genes directly from fastq files. It supports reads by finding reads that can be well mapped to the left and right parts of two different genes but cannot be completely mapped to the entire reference genome, and analyzes each supporting read to determine whether it is a fusion gene. However, this software can only focus on genes with clinical significance for research, and its detection ability for unknown fusion genes is weak. Factera is a software tool for discovering fusion genes from DNA sequencing. It is mainly used to detect translocation, inversion and deletion fusion gene types. The software first needs to align and process the original fastq file to obtain a bam file. Secondly, the bam file is used as the input file of the software. By finding incorrectly paired reads, the adjacent exons are clustered into different genomes, breakpoints are found and fusion genes are located. However, the software relies on bam files, is not sensitive enough to the detection results, and lacks the function of visually detecting fusions. Arriba is a fusion gene detection tool using RNA-based sequencing data. It can detect inversion and duplication fusion gene types, and is fast and sensitive, but it is difficult to detect missing fusion genes. It can be seen that each software has drawbacks in detecting fusion genes, and using a single software to detect fusion genes may result in false positives or false negatives. Summary of the invention
[0006] Based on the above problems, the present invention proposes a method for detecting fusion genes based on DNA-based sequencing data. This method constructs a screening standard based on multiple software and uses the current mainstream detection software for fusion genes for filtering and screening, effectively avoiding false positives or false negatives in the detection results of a single software.
[0007] A method for detecting fusion genes based on DNA-based sequencing data, the steps of which are:
[0008] Step S1: Obtain DNA sequencing data, use software fastp to filter the data, and obtain filtered sequencing data;
[0009] Step S2: Use the Genefuse software to perform fusion gene detection on the filtered sequencing data to obtain the first fusion gene result and first related parameter information;
[0010] Step S3: Use the software Factera to perform fusion gene detection on the filtered sequencing data to obtain the second fusion gene result and the second related parameter information;
[0011] Step S4: using the software Arriba to perform fusion gene detection on the filtered sequencing data to obtain the third fusion gene result and third related parameter information;
[0012] Step S5: Obtain a fusion gene filtering model, and use the first fusion gene result and the first related parameter, the second fusion gene result and the second related parameter, and the third fusion gene result and the third related parameter as input data, calculate the true positive fusion gene through the fusion gene filtering model, and output the fusion gene result.
[0013] Preferably, the first relevant parameter information in step S2 includes the number of breakpoints and the base quality of the breakpoint sequence, wherein the number of breakpoints is divided into a total number and a unique number, and the base quality is high quality, medium quality, low quality and very low quality respectively.
[0014] Preferably, the second relevant parameter information in step S3 includes break_support, break_depth, proper_pair_support and total_depth, wherein break_support is divided into break_support1 and break_support2.
[0015] Preferably, the third related parameter information in step S4 includes split_read, coverage and confidence, wherein split_read is divided into split_read1 and split_read2, coverage is divided into coverage1 and coverage2, and confidence is divided into low, medium and high.
[0016] Preferably, the fusion gene filtering model step described in step S5 is:
[0017] Step S51: respectively obtaining the first fusion gene result and the first related parameter information, the second fusion gene result and the second related parameter information, and the third fusion gene result and the third related parameter information, and obtaining a potential fusion gene table according to the above fusion gene results and related parameter information, the potential fusion gene table including: fusion gene pairs, fusion gene 1, fusion gene 2, detection software, sequence information and related parameters;
[0018] Step S52: if the fusion gene pair is detected in two or more fusion gene detection software, the fusion gene pair is set as a fusion gene list, and relevant parameter information is obtained;
[0019] Step S53: If the fusion gene pair is detected in only one fusion gene detection software, and its corresponding fusion gene 1 or fusion gene 2 is detected in multiple fusion gene detection software, then extract the corresponding fusion gene pair sequence information in multiple software, obtain the abnormal comparison sequence according to the DNA sequencing data, use the software BWA to compare the abnormal comparison sequence with the reference genome, and obtain the result of the fusion gene according to the comparison quality; if the comparison results of multiple abnormal comparison sequences are consistent, then obtain the fusion gene pair according to the comparison results, set the fusion gene pair as a fusion gene list, and obtain relevant parameter information; if the comparison results of multiple abnormal comparison sequences are inconsistent, select the comparison result with higher quality according to the comparison quality to obtain the fusion gene pair, set the fusion gene pair as a fusion gene list and obtain relevant parameter information; if the comparison results of multiple abnormal comparison sequences are inconsistent and the comparison quality is consistent, select the result with higher quality according to the base quality to obtain the fusion gene pair, set the fusion gene pair as a fusion gene list and obtain relevant parameter information;
[0020] Step S54: If the fusion gene pair is only detected in the first fusion gene result, and fusion gene 1 and fusion gene 2 are not detected in other fusion gene pairs, the first fusion gene result and related parameters are obtained for judgment: if the total number in the number of breakpoints is ≥20, the fusion gene pair is considered to be true positive, set as a fusion gene list, and obtain relevant parameter information; if 10≤the total number of breakpoints<20 and the number of low quality and very low quality bases is less than 15% of the length of the entire fusion gene pair, then according to the fusion gene pair sequence, the abnormal alignment sequence .fastq file is extracted from the DNA sequencing data, and the abnormal alignment sequence .fastq file is aligned and deduplicated using samtools software and picard software to obtain the abnormal alignment sequence .bam file, and the fusion gene is detected from the abnormal alignment sequence .bam file and the abnormal alignment .fastq file using Factera software and Arriba software respectively. If the same fusion gene pair is detected in one of the software, the fusion gene pair is considered to be true positive, set as a fusion gene list, and obtain relevant parameter information;
[0021] Step S55: If the fusion gene pair is only detected in the second fusion gene result, and fusion gene 1 and fusion gene 2 are not detected in other fusion gene pairs, then the relevant parameters of the second fusion gene result are obtained for judgment: if break_support≥20 and break_depth and proper_pair_support are both greater than 100, the fusion gene pair is considered to be true positive, set as a fusion gene list, and obtain relevant parameter information; if 10≤break_support<20, and break_depth, proper_pair_support and total_depth are all greater than 100, then the sequence information of the fusion gene pair is extracted, and the abnormal alignment sequence .fastq file is extracted from the DNA sequencing data, and the fusion gene is detected from the abnormal alignment sequence .fastq file using Genefuse software and Arriba software. If the same fusion gene pair is detected in one of the software, the fusion gene pair is considered to be true positive, and relevant parameter information is obtained;
[0022] Step S56: If the fusion gene pair is only detected in the third fusion gene result, and fusion gene 1 and fusion gene 2 are not detected in other fusion gene results, then the relevant parameters of the third fusion gene result are obtained for judgment: if confidence is high, and split_read≥20 and coverage≥200, the fusion gene pair is considered to be true positive, set as a fusion gene list, and obtain parameter information; if confidence is medium or low, 10≤split_read<20, coverage≥200, extract the sequence information of the fusion gene pair, and extract the abnormal alignment sequence .fastq file from the DNA sequencing data based on the information, use software BWA and software picard to analyze the abnormal alignment sequence .fastq file, obtain the abnormal alignment sequence .bam file, use software Genefuse and software Factera to perform fusion gene detection on the abnormal alignment sequence .fastq file and the abnormal alignment sequence .bam file, respectively, if any software detects the same fusion gene pair, then the fusion gene pair is considered to be true positive, set as a fusion gene list, and obtain relevant parameter information;
[0023] Step S57: Obtain a fusion gene list and output the result.
[0024] Compared with the prior art, the present invention has the following beneficial effects:
[0025] (1) The present invention uses three softwares (Genefuse, Factera and Arriba) based on different detection algorithms and different detection data to detect fusion genes, which can make up for the detection differences of different fusion gene types detected by a single software, and incorporates an RNA-based software to detect fusion genes from DNA-based sequencing data, which can effectively increase the detection rate of fusion genes detected in different algorithms;
[0026] (2) The present invention sets the filtering threshold of fusion genes and constructs a fusion gene filtering model through the effective parameters of each software, thereby improving the accuracy of fusion genes detected by each software and being able to provide more effective data support for guiding clinical diagnosis and medication. BRIEF DESCRIPTION OF THE DRAWINGS
[0027] Figure 1 Flow chart of a fusion gene detection method based on DNA-based sequencing data in an embodiment of the present invention.
[0028] Figure 2 Flow chart of the fusion gene filtering model in an embodiment of the present invention. DETAILED DESCRIPTION
[0029] The present invention is described in detail below with reference to the embodiments.
[0030] Embodiment 1:
[0031] A method for detecting fusion genes based on DNA-based sequencing data, such as Figure 1 As shown, the specific steps are as follows:
[0032] Step S1: Obtain DNA sequencing data, and use the software fastp to filter the data to obtain filtered sequencing data.
[0033] Specifically, the fastp software was used with the following data filtering criteria: filtering when the base quality was less than Q20, when the sequence contained N bases, and when the sequence length was less than 50 bp. The command line was: -q 20 -n 0 --length_required 50.
[0034] Step S2: Use the Genefuse software to perform fusion gene detection on the filtered sequencing data to obtain the first fusion gene result and first related parameter information;
[0035] Among them, the software Genefuse uses the human genome hg19 as the reference gene for comparison, and uses the database of all clinical disease-related fusion genes based on the reference genome hg19 as the fusion gene reference file.
[0036] The relevant parameter information in the software Genefuse includes: the number of breakpoints (including total number and unique number), diff value, and base quality of the breakpoint sequence; the total number is the total number of breakpoints detected in the fusion gene, the unique number is the number of non-repeated breakpoints detected in the fusion gene, and the diff value is expressed as (diff1|diff2), which is the editing distance between fusion gene 1 and fusion gene 2 in the fusion gene and the reference genome respectively; the base quality of the breakpoint sequence refers to the quality value of each base, which are extremely high quality (base quality>Q40), high quality (base quality: Q30~Q39), medium quality (base quality: Q20~Q29), low quality (base quality: Q15~Q19) and extremely low quality (base quality: 0~Q14).
[0037] In this embodiment, if more breakpoints are detected, it indicates that the breakpoints are more reliable, and if the quality of each base site of the fusion gene sequence is higher, it indicates that the quality of the sequence is higher and the detection result is more reliable.
[0038] Step S3: Use the software Factera to perform fusion gene detection on the filtered sequencing data to obtain the second fusion gene result and the second related parameter information;
[0039] In this embodiment, the steps of using the software Factera to perform fusion gene detection are as follows: (1) using the software BWA to compare the filtered sequencing data with the reference genome to obtain a compared bam file; (2) using the software picard to identify duplicates and filter the compared bam file to obtain a filtered bam file; (3) using the software Factera to perform fusion gene detection on the filtered bam file; wherein the human genome hg19 and its exons are used as the reference genome and reference exons.
[0040] Specifically, the relevant parameters of the software Factera include: break_support, break_depth, proper_pair_support, unmapped_support, improper_pair_support, paired_end_support and total_depth; among them, break_support is the number of read lengths supporting the breakpoint, which is divided into break_support1 and break_support2; break_depth is the number of read pairs spanning the breakpoint; proper_pair_support: the number of correctly paired and soft-cut read pairs; unmapped_support: the number of read pairs that were not previously mapped to the fusion; improper_pair_support: the number of inconsistent read length pairs; paired_end_support: the number of read pairs flanking the breakpoint; total_depth: the average total depth of the two breakpoint flanking regions.
[0041] In this embodiment, if the numbers of break_support, break_depth and proper_pair_support are larger, it means that the breakpoint is more credible, and if the total_depth is higher, it means that the sequencing depth near the breakpoint is higher, then the breakpoint is more credible.
[0042] Step S4: using the software Arriba to perform fusion gene detection on the filtered sequencing data to obtain the third fusion gene result and third related parameter information;
[0043] In this embodiment, the software Arriba uses the human genome hs37d5 as a reference genome; relevant parameters include: split_read, discordant_mates, coverage, and confidence, etc.; split_read is the number of read pairs supporting the breakpoint, which is divided into split_read1 and split_read2; discordant_mates indicates the number of inconsistently paired reads supporting fusion; coverage indicates the number of fragments near the breakpoint of the fusion gene, which is divided into coverage1 and coverage2; confidence is the confidence of each fusion gene, which is divided into low, medium, and high.
[0044] Among them, the higher the parameters split_read and coverage are, the higher the confidence of the fusion gene is. In this embodiment, split_read, coverage and confidence are selected as the third related parameters.
[0045] Step S5: obtaining a fusion gene filtering model, and using the first fusion gene result and the first related parameter, the second fusion gene result and the second related parameter, and the third fusion gene result and the third related parameter as input data, calculating true positive fusion genes through the fusion gene filtering model, and outputting the fusion gene results;
[0046] The flowchart of the fusion gene filtering model is as follows: Figure 2 As shown, the specific steps include:
[0047] Step S51: respectively obtaining the first fusion gene result and the first related parameter information, the second fusion gene result and the second related parameter information, and the third fusion gene result and the third related parameter information, and obtaining a potential fusion gene table according to the above fusion gene results and related parameter information, the potential fusion gene table including: fusion gene pairs, fusion gene 1, fusion gene 2, detection software, sequence information and related parameters;
[0048] Step S52: if the fusion gene pair is detected in two or more fusion gene detection software, the fusion gene pair is set as a fusion gene list, and relevant parameter information is obtained;
[0049] Step S53: If the fusion gene pair is detected in only one fusion gene detection software, and its corresponding fusion gene 1 or fusion gene 2 is detected in multiple fusion gene detection software, then extract the corresponding fusion gene pair sequence information in multiple software, obtain the abnormal comparison sequence according to the DNA sequencing data, use the software BWA to compare the abnormal comparison sequence with the reference genome, and obtain the result of the fusion gene according to the comparison quality: if the comparison results of multiple abnormal comparison sequences are consistent, then obtain the fusion gene pair according to the comparison results, set the fusion gene pair as a fusion gene list, and obtain relevant parameter information; if the comparison results of multiple abnormal comparison sequences are inconsistent, select the comparison result with higher quality according to the comparison quality to obtain the fusion gene pair, set the fusion gene pair as a fusion gene list and obtain relevant parameter information; if the comparison results of multiple abnormal comparison sequences are inconsistent and the comparison quality is consistent, select the result with higher quality according to the base quality to obtain the fusion gene pair, set the fusion gene pair as a fusion gene list and obtain relevant parameter information;
[0050] Step S54: If the fusion gene pair is only detected in the first fusion gene result, and fusion gene 1 and fusion gene 2 are not detected in other fusion gene pairs, the first fusion gene result and related parameters are obtained for judgment: if the total number in the number of breakpoints is ≥20, the fusion gene pair is considered to be true positive, set as a fusion gene list, and obtain relevant parameter information; if 10≤the total number of breakpoints<20 and the number of low quality and very low quality bases is less than 15% of the length of the entire fusion gene pair, then according to the fusion gene pair sequence, the abnormal alignment sequence .fastq file is extracted from the DNA sequencing data, and the abnormal alignment sequence .fastq file is aligned and deduplicated using samtools software and picard software to obtain the abnormal alignment sequence .bam file, and the fusion gene is detected from the abnormal alignment sequence .bam file and the abnormal alignment sequence .fastq file using Factera software and Arriba software respectively. If the same fusion gene pair is detected in one of the software, the fusion gene pair is considered to be true positive, set as a fusion gene list, and obtain relevant parameter information;
[0051] Step S55: If the fusion gene pair is only detected in the second fusion gene result, and fusion gene 1 and fusion gene 2 are not detected in other fusion gene pairs, then the relevant parameters of the second fusion gene result are obtained for judgment: if break_support≥20 and break_depth and proper_pair_support are both greater than 100, the fusion gene pair is considered to be true positive, set as a fusion gene list, and obtain relevant parameter information; if 10≤break_support<20, and break_depth, proper_pair_support and total_depth are all greater than 100, then the sequence information of the fusion gene pair is extracted, and the abnormal alignment sequence .fastq file is extracted from the DNA sequencing data, and the fusion gene is detected from the abnormal alignment sequence .fastq file using Genefuse software and Arriba software. If the same fusion gene pair is detected in one of the software, the fusion gene pair is considered to be true positive, and relevant parameter information is obtained;
[0052] Step S56: If the fusion gene pair is only detected in the third fusion gene result, and fusion gene 1 and fusion gene 2 are not detected in other fusion gene results, then the relevant parameters of the third fusion gene result are obtained for judgment: if confidence is high, and spilt_read≥20 and coverage≥200, the fusion gene pair is considered to be true positive, set as a fusion gene list, and obtain parameter information; if confidence is medium or low, 10≤split_read<20, coverage≥200, extract the sequence information of the fusion gene pair, and extract the abnormal alignment sequence .fastq file from the DNA sequencing data according to the information, use software BWA and software picard to analyze the abnormal alignment sequence .fastq file, obtain the abnormal alignment sequence .bam file, use software Genefuse and software Factera to perform fusion gene detection on the abnormal alignment sequence .fastq file and the abnormal alignment sequence .bam file, respectively, if any software detects the same fusion gene pair, then the fusion gene pair is considered to be true positive, set as a fusion gene list, and obtain relevant parameter information;
[0053] The step of extracting abnormal alignment sequences is as follows: comparing the obtained potential breakpoint sequence information with the filtered sequencing data, and extracting sequences with alignment consistency rates greater than 95% as abnormal alignment sequences.
[0054] Step S57: Obtain a fusion gene list and output the result.
[0055] Embodiment 2:
[0056] According to the steps of Example 1, fusion gene detection was performed on 6 samples, wherein the first fusion gene results obtained in step S2 of the six samples are shown in Table 1.
[0057] Table 1: Fusion gene detection results and related parameter information based on Genefuse software:
[0058] Sample No. Fusion gene Gene 1 Gene 2 total number Unique quantity Base quality ratio of breakpoint sequence S1 EML4-ALK EML4 ALK 66 35 3.8% S2 BCR-ALK BCR ALK 6 2 5.6% S3 RET-KIF5B RET KIF5B 10 8 11.3% S4 CD74-ALK CD74 ALK 12 2 2.7% S4 NTRK1-ROS1 NTRK1 ROS1 25 2 3.1% S5 RET-CCDC6 RET CCDC6 35 24 7.1% S6 RET-KIF5B RET KIF5B 60 27 2.1%
[0059] In this embodiment, the base quality ratio of the breakpoint sequence is less than the base quality ratio of Q20.
[0060] According to step S3, the fusion gene detection is performed on the six samples to obtain the second fusion gene results, as shown in Table 2:
[0061] Table 2: Fusion gene detection results and related parameter information based on Factera software:
[0062]
[0063]
[0064] Among them, “-” indicates an unknown fusion gene type.
[0065] According to step S4, the six samples are tested for fusion genes to obtain the third fusion gene results, as shown in Table 3;
[0066] Table 3: Fusion gene detection results and related parameter information based on software Arriba:
[0067]
[0068]
[0069] In this embodiment, no fusion gene was detected in sample S4 using the software Arriba.
[0070] According to step S5, the first fusion gene results, the second fusion gene results, and the third fusion gene results of the six samples are calculated using the fusion gene filtering model to obtain true positive fusion genes. The fusion gene results are shown in Table 4:
[0071] Table 4: Final fusion gene results:
[0072] Sample No. Fusion gene Software 1 Software 2 Software 3 Detection S1 RRM1-AS1-IQGAP3 × × √ × S1 EML4-ALK √ √ √ √ S2 ASXL1-RP5-963E22.4 × × √ × S2 BCR-ALK √ × × × S2 FGF7-ANKRD20A2 × √ × √ S2 PAIP2B-NUTM1 × √ × × S2 YTHDF1-ASXL1 × √ × × S3 RET-KIF5B √ √ × √ S3 HLA-DRB5-HLA-DRB1 × √ × √ S3 LYZL2-RET × √ √ √ S4 NTRK1-ROS1 √ × × √ S4 TUBA3D-GNAQ × √ × × S5 RET-CCDC6 √ √ × √ S5 RET-TCERG1L × × √ × S6 RET-KIF5B √ × × √ S6 SLC36A4-PNPLA3 × √ √ √ S6 CCL11-PNPLA3 × √ × × S6 PNPLA3-TWIST2 × √ × × S6 RET-RASGEF1A × √ × √ S6 SUMF1-PNPLA3 × × √ × S6 RRM1-AS1-IQGAP3 × × √ ×
[0073] According to the above results, the method of the present invention can be used to detect fusion genes. Compared with the fusion gene results detected by a single software, the present invention can increase the accuracy of fusion gene detection. For example, the fusion gene LYZL2-RET of sample S3 is detected in both software Factera and Arriba, but the detection frequency is low. If a single software is used for detection, the fusion gene result may be filtered. However, the detection accuracy of the fusion gene can be increased by using the method of the present invention to verify the detection results of the two softwares. Secondly, the present invention can effectively reduce the false negative detection of fusion genes. For example, the fusion gene FGF7-ANKRD20A2 of sample S2 is only detected in software Factera, and the detection frequency is high. After calculation by the fusion gene filtering model, it is concluded that the fusion gene is a true positive. Therefore, the present invention can reduce the false positives and false negatives of fusion gene detection in DNA-based sequencing data, and improve the accuracy of fusion gene detection.
Claims
1. A method for detecting fusion genes based on DNA-based sequencing data, characterized in that the steps include: Step S1: Obtain DNA sequencing data, use software fastp to filter the data, and obtain filtered sequencing data; Step S2: Use the Genefuse software to perform fusion gene detection on the filtered sequencing data to obtain the first fusion gene result and first related parameter information; Step S3: Use the software Factera to perform fusion gene detection on the filtered sequencing data to obtain the second fusion gene result and the second related parameter information; Step S4: using the software Arriba to perform fusion gene detection on the filtered sequencing data to obtain the third fusion gene result and third related parameter information; Step S5: Obtain a fusion gene filtering model, and use the first fusion gene result and the first related parameter, the second fusion gene result and the second related parameter, and the third fusion gene result and the third related parameter as input data, calculate the true positive fusion gene through the fusion gene filtering model, and output the fusion gene result.
2. The method for detecting fusion genes based on DNA-based sequencing data according to claim 1, characterized in that: The first relevant parameter information described in step S2 includes the number of breakpoints and the base quality of the breakpoint sequence, wherein the number of breakpoints is divided into a total number and a unique number, and the base quality is divided into very high quality, high quality, medium quality, low quality and very low quality.
3. The method for detecting fusion genes based on DNA-based sequencing data according to claim 1, characterized in that: The second related parameter information in step S3 includes break_support, break_depth, proper_pair_support and total_depth, wherein break_support is divided into break_support1 and break_support2.
4. The method for detecting fusion genes based on DNA-based sequencing data according to claim 1, characterized in that: The third related parameter information in step S4 includes split_read, coverage and confidence, wherein split_read is divided into split_read1 and split_read2, coverage is divided into coverage1 and coverage2, and confidence is divided into low, medium and high.
5. The method for detecting fusion genes based on DNA-based sequencing data according to claim 1, characterized in that: The steps of the fusion gene filtering model described in step S5 are: Step S51: respectively obtaining the first fusion gene result and the first related parameter information, the second fusion gene result and the second related parameter information, and the third fusion gene result and the third related parameter information, and obtaining a potential fusion gene table according to the above fusion gene results and related parameter information, the potential fusion gene table including: fusion gene pairs, fusion gene 1, fusion gene 2, detection software, sequence information and related parameters; Step S52: if the fusion gene pair is detected in two or more fusion gene detection software, the fusion gene pair is set as a fusion gene list, and relevant parameter information is obtained; Step S53: If the fusion gene pair is detected in only one fusion gene detection software, and its corresponding fusion gene 1 or fusion gene 2 is detected in multiple fusion gene detection software, then extract the corresponding fusion gene pair sequence information in multiple software, obtain the abnormal comparison sequence according to the DNA sequencing data, use the software BWA to compare the abnormal comparison sequence with the reference genome, and obtain the result of the fusion gene according to the comparison quality: if the comparison results of multiple abnormal comparison sequences are consistent, then obtain the fusion gene pair according to the comparison results, set the fusion gene pair as a fusion gene list, and obtain relevant parameter information; if the comparison results of multiple abnormal comparison sequences are inconsistent, select the comparison result with higher quality according to the comparison quality to obtain the fusion gene pair, set the fusion gene pair as a fusion gene list and obtain relevant parameter information; if the comparison results of multiple abnormal comparison sequences are inconsistent and the comparison quality is consistent, select the result with higher quality according to the base quality to obtain the fusion gene pair, set the fusion gene pair as a fusion gene list and obtain relevant parameter information; Step S54: If the fusion gene pair is only detected in the first fusion gene result, and fusion gene 1 and fusion gene 2 are not detected in other fusion gene pairs, the first fusion gene result and related parameters are obtained for judgment: if the total number in the number of breakpoints is ≥20, the fusion gene pair is considered to be true positive, set as a fusion gene list, and obtain relevant parameter information; if 10≤the total number of breakpoints<20 and the number of low quality and very low quality bases is less than 15% of the length of the entire fusion gene pair, then according to the fusion gene pair sequence, the abnormal alignment sequence .fastq file is extracted from the DNA sequencing data, and the abnormal alignment sequence .fastq file is aligned and deduplicated using samtools software and picard software to obtain the abnormal alignment sequence .bam file, and the fusion gene is detected from the abnormal alignment sequence .bam file and the abnormal alignment sequence .fastq file using Factera software and Arriba software respectively. If the same fusion gene pair is detected in one of the software, the fusion gene pair is considered to be true positive, set as a fusion gene list, and obtain relevant parameter information; Step S55: If the fusion gene pair is only detected in the second fusion gene result, and fusion gene 1 and fusion gene 2 are not detected in other fusion gene pairs, then the relevant parameters of the second fusion gene result are obtained for judgment: if break_support≥20 and break_depth and proper_pair_support are both greater than 100, the fusion gene pair is considered to be true positive, set as a fusion gene list, and obtain relevant parameter information; if 10≤break_support<20, and break_depth, proper_pair_support and total_depth are all greater than 100, then the sequence information of the fusion gene pair is extracted, and the abnormal alignment sequence .fastq file is extracted from the DNA sequencing data, and the fusion gene is detected from the abnormal alignment sequence .fastq file using Genefuse software and Arriba software. If the same fusion gene pair is detected in one of the software, the fusion gene pair is considered to be true positive, and relevant parameter information is obtained; Step S56: If the fusion gene pair is only detected in the third fusion gene result, and fusion gene 1 and fusion gene 2 are not detected in other fusion gene results, then the relevant parameters of the third fusion gene result are obtained for judgment: if confidence is high, and spilt_read≥20 and coverage≥200, the fusion gene pair is considered to be true positive, set as a fusion gene list, and obtain parameter information; if confidence is medium or low, 10≤split_read<20, coverage≥200, extract the sequence information of the fusion gene pair, and extract the abnormal alignment sequence .fastq file from the DNA sequencing data according to the information, use software BWA and software picard to analyze the abnormal alignment sequence .fastq file, obtain the abnormal alignment sequence .bam file, use software Genefuse and software Factera to perform fusion gene detection on the abnormal alignment sequence .fastq file and the abnormal alignment sequence .bam file, respectively, if any software detects the same fusion gene pair, then the fusion gene pair is considered to be true positive, set as a fusion gene list, and obtain relevant parameter information; Step S57: Obtain a fusion gene list and output the result.
Citation Information
Patent Citations
Fusion gene detection method and device based on RNAseq data and storage medium
CN112164423A
False positive filtering method for next-generation sequencing RNA (Ribonucleic Acid) fusion
CN117688225A
Fusion gene detection method based on DNA or RNA sequencing technology
CN117746988A
